Related Experiment Videos
Ocular pigmented spots and eyelid myxomas
R H Kennedy1, R R Waller, J A Carney
1Department of Ophthalmology, Mayo Clinic, Rochester, MN 55905.
American Journal of Ophthalmology
|November 15, 1987
Summary
Ophthalmic abnormalities like lentigines and eyelid myxomas are key early signs of a syndrome involving myxomas and endocrine issues. Recognizing these eye findings is crucial for early diagnosis of this inherited condition.
Area of Science:
- Ophthalmology
- Genetics
- Endocrinology
Background:
- A recently identified syndrome links ophthalmic abnormalities with myxomas and endocrine overactivity.
- This complex genetic disorder follows a Mendelian dominant inheritance pattern.
- Understanding the full spectrum of this syndrome is essential for patient management.
Observation:
- Facial and eyelid lentigines were observed in 70% of patients.
- Pigmented lesions on the caruncle or conjunctival semilunar fold occurred in 27% of patients.
- Eyelid myxomas were present in 16% of the identified cases.
Findings:
- Ophthalmic abnormalities are frequently the earliest manifestations of the syndrome.
- The prevalence of specific eye findings includes lentigines, pigmented lesions, and eyelid myxomas.
- These ocular signs can precede more severe systemic manifestations, such as cardiac myxoma.
Implications:
- Early recognition of ophthalmic abnormalities is critical for timely diagnosis of the syndrome.
- Ophthalmologists play a key role in identifying patients at risk.
- Prompt diagnosis allows for earlier intervention and management of associated systemic conditions.